دورية أكاديمية
The Identification of Novel Biomarkers Is Required to Improve Adult SMA Patient Stratification, Diagnosis and Treatment
العنوان: | The Identification of Novel Biomarkers Is Required to Improve Adult SMA Patient Stratification, Diagnosis and Treatment |
---|---|
المؤلفون: | Piera Smeriglio, Paul Langard, Giorgia Querin, Maria Grazia Biferi |
المصدر: | Journal of Personalized Medicine; Volume 10; Issue 3; Pages: 75 |
بيانات النشر: | Multidisciplinary Digital Publishing Institute |
سنة النشر: | 2020 |
المجموعة: | MDPI Open Access Publishing |
مصطلحات موضوعية: | spinal muscular atrophy, adult patients, disease heterogeneity, Nusinersen, disease modifiers, functional outcomes, biomarkers, epigenetic changes, omics approaches |
الوصف: | Spinal muscular atrophy (SMA) is currently classified into five different subtypes, from the most severe (type 0) to the mildest (type 4) depending on age at onset, best motor function achieved, and copy number of the SMN2 gene. The two recent approved treatments for SMA patients revolutionized their life quality and perspectives. However, upon treatment with Nusinersen, the most widely administered therapy up to date, a high degree of variability in therapeutic response was observed in adult SMA patients. These data, together with the lack of natural history information and the wide spectrum of disease phenotypes, suggest that further efforts are needed to develop precision medicine approaches for all SMA patients. Here, we compile the current methods for functional evaluation of adult SMA patients treated with Nusinersen. We also present an overview of the known molecular changes underpinning disease heterogeneity. We finally highlight the need for novel techniques, i.e., -omics approaches, to capture phenotypic differences and to understand the biological signature in order to revise the disease classification and device personalized treatments. |
نوع الوثيقة: | text |
وصف الملف: | application/pdf |
اللغة: | English |
العلاقة: | Omics/Informatics; https://dx.doi.org/10.3390/jpm10030075Test |
DOI: | 10.3390/jpm10030075 |
الإتاحة: | https://doi.org/10.3390/jpm10030075Test |
حقوق: | https://creativecommons.org/licenses/by/4.0Test/ |
رقم الانضمام: | edsbas.10822D6B |
قاعدة البيانات: | BASE |
ResultId |
1 |
---|---|
Header |
edsbas BASE edsbas.10822D6B 918 3 Academic Journal academicJournal 917.616333007813 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.10822D6B&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.3390/jpm10030075# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => The Identification of Novel Biomarkers Is Required to Improve Adult SMA Patient Stratification, Diagnosis and Treatment
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Piera+Smeriglio%22">Piera Smeriglio</searchLink><br /><searchLink fieldCode="AR" term="%22Paul+Langard%22">Paul Langard</searchLink><br /><searchLink fieldCode="AR" term="%22Giorgia+Querin%22">Giorgia Querin</searchLink><br /><searchLink fieldCode="AR" term="%22Maria+Grazia+Biferi%22">Maria Grazia Biferi</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Journal of Personalized Medicine; Volume 10; Issue 3; Pages: 75 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Multidisciplinary Digital Publishing Institute ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2020 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => MDPI Open Access Publishing ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22spinal+muscular+atrophy%22">spinal muscular atrophy</searchLink><br /><searchLink fieldCode="DE" term="%22adult+patients%22">adult patients</searchLink><br /><searchLink fieldCode="DE" term="%22disease+heterogeneity%22">disease heterogeneity</searchLink><br /><searchLink fieldCode="DE" term="%22Nusinersen%22">Nusinersen</searchLink><br /><searchLink fieldCode="DE" term="%22disease+modifiers%22">disease modifiers</searchLink><br /><searchLink fieldCode="DE" term="%22functional+outcomes%22">functional outcomes</searchLink><br /><searchLink fieldCode="DE" term="%22biomarkers%22">biomarkers</searchLink><br /><searchLink fieldCode="DE" term="%22epigenetic+changes%22">epigenetic changes</searchLink><br /><searchLink fieldCode="DE" term="%22omics+approaches%22">omics approaches</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Spinal muscular atrophy (SMA) is currently classified into five different subtypes, from the most severe (type 0) to the mildest (type 4) depending on age at onset, best motor function achieved, and copy number of the SMN2 gene. The two recent approved treatments for SMA patients revolutionized their life quality and perspectives. However, upon treatment with Nusinersen, the most widely administered therapy up to date, a high degree of variability in therapeutic response was observed in adult SMA patients. These data, together with the lack of natural history information and the wide spectrum of disease phenotypes, suggest that further efforts are needed to develop precision medicine approaches for all SMA patients. Here, we compile the current methods for functional evaluation of adult SMA patients treated with Nusinersen. We also present an overview of the known molecular changes underpinning disease heterogeneity. We finally highlight the need for novel techniques, i.e., -omics approaches, to capture phenotypic differences and to understand the biological signature in order to revise the disease classification and device personalized treatments. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => text ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => Omics/Informatics; https://dx.doi.org/10.3390/jpm10030075 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.3390/jpm10030075 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.3390/jpm10030075 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => https://creativecommons.org/licenses/by/4.0/ ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.10822D6B ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.3390/jpm10030075
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => spinal muscular atrophy
[Type] => general
)
[1] => Array
(
[SubjectFull] => adult patients
[Type] => general
)
[2] => Array
(
[SubjectFull] => disease heterogeneity
[Type] => general
)
[3] => Array
(
[SubjectFull] => Nusinersen
[Type] => general
)
[4] => Array
(
[SubjectFull] => disease modifiers
[Type] => general
)
[5] => Array
(
[SubjectFull] => functional outcomes
[Type] => general
)
[6] => Array
(
[SubjectFull] => biomarkers
[Type] => general
)
[7] => Array
(
[SubjectFull] => epigenetic changes
[Type] => general
)
[8] => Array
(
[SubjectFull] => omics approaches
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => The Identification of Novel Biomarkers Is Required to Improve Adult SMA Patient Stratification, Diagnosis and Treatment
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Piera Smeriglio
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Paul Langard
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Giorgia Querin
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Maria Grazia Biferi
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2020
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Journal of Personalized Medicine; Volume 10; Issue 3; Pages: 75
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |